| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/27/2002 | US20020082256 Compounds useful as anti-inflammatory agents |
| 06/27/2002 | US20020082254 Inhibitors of hormone-sensitive lipase; decreasing plasma free fatty acid levels found with diabetes type 2, insulin resistance, impaired glucose tolerance, hyperglycemia, dyslipidemia, or lipoprotein metabolism abnormalities |
| 06/27/2002 | US20020082219 Dendroaspis(green mamba snake) natriuretic peptide has at least one activity selected from the group consisting of vasodilation, antriuresis, diuresis and renin-suppressing activity |
| 06/27/2002 | US20020082202 Screening methods using ligands of the neutropeptide receptor HFGAN72 |
| 06/27/2002 | US20020082199 Insoluble insulin compositions |
| 06/27/2002 | US20020082193 Inhibition of mitochondrial calcium/sodium antiporter |
| 06/27/2002 | US20020081605 Method for detecting growth hormone variations in humans, the variations and their uses |
| 06/27/2002 | US20020081360 Salts of L-amino acid having improved taste and their preparation |
| 06/27/2002 | US20020081315 Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 06/27/2002 | US20020081314 Starch and protein from a mixture of embryo bud and seed coat of rice and fruit body of ganoderma lucidum are decomposed by aspergills oryzae with added B vitamins, and the enzyme retain their catalytic activity; prevent autoimmune diabetes |
| 06/27/2002 | US20020081300 Administering the combination of anti-glutamic acid decarboxylase (anti-GAD) antibody and anti-insulin antibody in amount effective to treat or prevent diabetes |
| 06/27/2002 | US20020081290 Protein kinase homologs |
| 06/27/2002 | US20020081285 Treatment for diabetes |
| 06/27/2002 | US20020081263 Methods for decreasing beta amyloid protein |
| 06/27/2002 | DE10064387A1 Redispersible dry powder containing oxygen-containing carotenoid, useful e.g. as dye in foods, feed or pharmaceuticals, prepared in presence of partially degraded soya protein as protective colloid |
| 06/27/2002 | CA2442181A1 Method for purification of lactose |
| 06/27/2002 | CA2436699A1 Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists |
| 06/27/2002 | CA2433027A1 Nucleic acid-associated proteins |
| 06/27/2002 | CA2432908A1 Diamines as modulators of chemokine receptor activity |
| 06/27/2002 | CA2432638A1 Therapeutic combination of amlodipine and benazepril |
| 06/27/2002 | CA2432315A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | CA2432282A1 Therapeutic combination of amlodipine and benazepril/benazeprilat |
| 06/27/2002 | CA2432035A1 Triglyceride depressant composition |
| 06/27/2002 | CA2431995A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| 06/27/2002 | CA2431994A1 Method for the production of polyfructans |
| 06/27/2002 | CA2431985A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| 06/27/2002 | CA2431495A1 A process for preparing vegetable oil fractions rich in non-tocolic, high-melting, unsaponifiable matter |
| 06/27/2002 | CA2431147A1 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 06/27/2002 | CA2431139A1 Oxidoreductases |
| 06/27/2002 | CA2431074A1 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (1) |
| 06/27/2002 | CA2431023A1 Substituted benzoindoles as spla2 inhibitors |
| 06/27/2002 | CA2430595A1 Dissociated glucocorticoid receptor antagonists for the treatment of glucocorticoid associated side-effect |
| 06/26/2002 | EP1217001A1 Quinuclidine compounds and drugs containing the same as the active ingredient |
| 06/26/2002 | EP1216703A2 Thiocarbamate sulfoxide composition for deterring ethanol ingestion |
| 06/26/2002 | EP1216247A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 06/26/2002 | EP1216232A1 Heterocyclic compounds and methods for modulating cxcr3 function |
| 06/26/2002 | EP1216221A2 Rxr modulators with improved pharmacologic profile |
| 06/26/2002 | EP1216057A1 Stable calcitriol solution for packaging in vials |
| 06/26/2002 | EP1216050A2 Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract |
| 06/26/2002 | EP1216048A2 Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols |
| 06/26/2002 | EP1216041A2 High lipid diet |
| 06/26/2002 | EP1216040A1 Agents for reducing cholesterol-uptake and lipid-uptake |
| 06/26/2002 | EP1216038A2 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 06/26/2002 | EP1216037A2 Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| 06/26/2002 | EP1216025A1 Dispersion formulations containing lipase inhibitors |
| 06/26/2002 | EP0894084B1 Cinnamic acid derivatives and their use as integrin antagonists |
| 06/26/2002 | EP0820441B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
| 06/26/2002 | EP0754050B1 Anti gram positive bacterial methods and materials |
| 06/26/2002 | EP0693933B1 Methods and compositions for delaying or preventing the onset of autoimmune disease |
| 06/26/2002 | EP0691814B1 Method and composition for treatment of osteoporosis |
| 06/26/2002 | CN1355881A Growth differentiation factor inhibitors and uses therefor |
| 06/26/2002 | CN1355852A T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection |
| 06/26/2002 | CN1355813A Peptide having preptin functionality |
| 06/26/2002 | CN1355811A Integrain receptor antagaonists |
| 06/26/2002 | CN1355801A Thiazolidinedione derivative and its use as antidiabetic |
| 06/26/2002 | CN1355800A Thiazolidinedione derivative and use as antidiabetic |
| 06/26/2002 | CN1355799A 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 06/26/2002 | CN1355702A Use of arylalkanoylpyridazines |
| 06/26/2002 | CN1355693A Controlled release and taste masking oral pharmaceutical compositions |
| 06/26/2002 | CN1355672A Method of increasing content of flavonoids and phenolic substances in plants |
| 06/26/2002 | CN1355169A Vanadium compound and its preparing process and usage |
| 06/26/2002 | CN1355038A Health-care product prepared from arnebia seed and its preparing process |
| 06/26/2002 | CN1086704C Compound having antihypertensive, cardioprotective, anti-ischemic and ant ilipolytic functions |
| 06/26/2002 | CN1086581C Tonic oligofructose salt as oral liquid |
| 06/26/2002 | CN1086576C Hypoglycemic agents |
| 06/25/2002 | US6410802 Etherification in presence of base |
| 06/25/2002 | US6410787 Process to prepare 2-aminoindan derivatives |
| 06/25/2002 | US6410739 Indole derivatives as 5-HT1 agonists |
| 06/25/2002 | US6410729 Substituted pyrimidine compounds and methods of use |
| 06/25/2002 | US6410596 For lowering blood glucose in a mammal |
| 06/25/2002 | US6410590 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 06/25/2002 | US6410589 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/25/2002 | US6410585 Therapy for non-insulin depend diabetes |
| 06/25/2002 | US6410577 Administered as anorexigenic agents, dietetics, antidiabetics and for enhancing lipid metabolism |
| 06/25/2002 | US6410564 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 06/25/2002 | US6410550 Aryl fused azapolycyclic compounds |
| 06/25/2002 | US6410540 Inhibitors of p38-αkinase |
| 06/25/2002 | US6410535 Prophylactic or therapeutic agents for diseases having vascular dysfunction associated with insulin resistance |
| 06/25/2002 | US6410532 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 06/25/2002 | US6410529 Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonists |
| 06/25/2002 | US6410520 Heating in aqueous solution |
| 06/25/2002 | US6410513 Polypeptides |
| 06/25/2002 | US6410316 Methods for producing a vector producing cell line utilizing a high multiplicity of transduction |
| 06/25/2002 | US6410022 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 06/25/2002 | US6410020 Monoclonal antibody reactive to human CETP and assay method for human CETP |
| 06/25/2002 | US6410016 Method for administering viable microorganism composition for poultry |
| 06/25/2002 | CA2240964C Piperidone tachykinin antagonists |
| 06/25/2002 | CA2220024C Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents |
| 06/25/2002 | CA2213609C New compounds to modulate hormone receptors, compositions containing them, and their therapeutic use |
| 06/25/2002 | CA2203878C Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 06/25/2002 | CA2140281C Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 06/20/2002 | WO2002048715A2 Inflammatory markers for detection and prevention of diabetes mellitus |
| 06/20/2002 | WO2002048337A2 Secreted human proteins |
| 06/20/2002 | WO2002048179A1 Gamma-ketoacid dipeptide derivatives as inhibitors of caspase-3 |
| 06/20/2002 | WO2002048154A2 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent |
| 06/20/2002 | WO2002048152A2 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |
| 06/20/2002 | WO2002048148A2 Pyrazolopyridine derivatives |
| 06/20/2002 | WO2002048134A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists |
| 06/20/2002 | WO2002048124A2 Piperazine derivatives |
| 06/20/2002 | WO2002048117A1 Quinazolinone derivatives |